| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.34e-06 | 14 | 32 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 6.48e-06 | 23 | 32 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.33e-05 | 29 | 32 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | filamin binding | 1.33e-05 | 29 | 32 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.16e-05 | 34 | 32 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | glycolipid binding | 6.55e-05 | 49 | 32 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 8.64e-05 | 147 | 32 | 4 | GO:0042826 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 8.89e-05 | 9 | 32 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | histone H4K8 acetyltransferase activity | 1.36e-04 | 11 | 32 | 2 | GO:0043996 | |
| GeneOntologyMolecularFunction | histone H4K5 acetyltransferase activity | 1.36e-04 | 11 | 32 | 2 | GO:0043995 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.45e-04 | 320 | 32 | 5 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.58e-04 | 326 | 32 | 5 | GO:0001217 | |
| GeneOntologyMolecularFunction | histone H4K12 acetyltransferase activity | 1.63e-04 | 12 | 32 | 2 | GO:0043997 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.90e-04 | 70 | 32 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.15e-04 | 73 | 32 | 3 | GO:0170055 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.58e-04 | 15 | 32 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 4.00e-04 | 90 | 32 | 3 | GO:0008028 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 6.16e-04 | 23 | 32 | 2 | GO:0010485 | |
| GeneOntologyMolecularFunction | phosphatase binding | 8.03e-04 | 264 | 32 | 4 | GO:0019902 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.56e-03 | 316 | 32 | 4 | GO:0035091 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 1.66e-03 | 815 | 32 | 6 | GO:0042803 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.72e-03 | 1459 | 32 | 8 | GO:0000977 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.72e-03 | 149 | 32 | 3 | GO:1990782 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.17e-03 | 582 | 32 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | protein kinase binding | 2.35e-03 | 873 | 32 | 6 | GO:0019901 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 2.64e-03 | 173 | 32 | 3 | GO:0070851 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.02e-03 | 51 | 32 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 3.50e-03 | 55 | 32 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.75e-03 | 196 | 32 | 3 | GO:0005319 | |
| GeneOntologyMolecularFunction | kinase binding | 3.94e-03 | 969 | 32 | 6 | GO:0019900 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 4.16e-03 | 60 | 32 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.36e-03 | 207 | 32 | 3 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.42e-03 | 208 | 32 | 3 | GO:0005342 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 4.54e-03 | 210 | 32 | 3 | GO:0019903 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 5.78e-03 | 229 | 32 | 3 | GO:0003714 | |
| GeneOntologyMolecularFunction | calmodulin binding | 5.85e-03 | 230 | 32 | 3 | GO:0005516 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 6.12e-03 | 1412 | 32 | 7 | GO:0000981 | |
| GeneOntologyMolecularFunction | transcription factor binding | 6.51e-03 | 753 | 32 | 5 | GO:0008134 | |
| GeneOntologyMolecularFunction | actin binding | 6.91e-03 | 479 | 32 | 4 | GO:0003779 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 6.93e-03 | 78 | 32 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | histone binding | 8.63e-03 | 265 | 32 | 3 | GO:0042393 | |
| GeneOntologyMolecularFunction | phospholipid binding | 1.10e-02 | 548 | 32 | 4 | GO:0005543 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 1.12e-02 | 1205 | 32 | 6 | GO:0046983 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.13e-02 | 293 | 32 | 3 | GO:0008514 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.16e-02 | 102 | 32 | 2 | GO:0016410 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.18e-02 | 560 | 32 | 4 | GO:0001228 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.20e-02 | 104 | 32 | 2 | GO:0016407 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.22e-02 | 566 | 32 | 4 | GO:0001216 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.29e-02 | 1244 | 32 | 6 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.43e-02 | 1271 | 32 | 6 | GO:0000987 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 1.48e-02 | 324 | 32 | 3 | GO:0005126 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.22e-06 | 14 | 32 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.52e-06 | 15 | 32 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.52e-06 | 15 | 32 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.52e-06 | 15 | 32 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.52e-06 | 15 | 32 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.87e-06 | 16 | 32 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 2.27e-06 | 17 | 32 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 2.27e-06 | 17 | 32 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 2.27e-06 | 17 | 32 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.72e-06 | 18 | 32 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 3.80e-06 | 20 | 32 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 4.43e-06 | 21 | 32 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 4.43e-06 | 21 | 32 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 4.43e-06 | 21 | 32 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 5.12e-06 | 22 | 32 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 5.88e-06 | 23 | 32 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.88e-06 | 23 | 32 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 6.71e-06 | 24 | 32 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 6.71e-06 | 24 | 32 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 6.71e-06 | 24 | 32 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 7.62e-06 | 25 | 32 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 7.62e-06 | 25 | 32 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 9.67e-06 | 27 | 32 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.08e-05 | 28 | 32 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.21e-05 | 29 | 32 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.48e-05 | 31 | 32 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.63e-05 | 32 | 32 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.63e-05 | 32 | 32 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.63e-05 | 32 | 32 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.79e-05 | 33 | 32 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.79e-05 | 33 | 32 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.96e-05 | 34 | 32 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.96e-05 | 34 | 32 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.15e-05 | 35 | 32 | 3 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.76e-05 | 38 | 32 | 3 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 2.98e-05 | 39 | 32 | 3 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 3.22e-05 | 40 | 32 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 3.47e-05 | 41 | 32 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 3.53e-05 | 1413 | 32 | 10 | GO:1902679 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 3.74e-05 | 42 | 32 | 3 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 4.60e-05 | 45 | 32 | 3 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelium development | 4.92e-05 | 1469 | 32 | 10 | GO:0060429 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 4.92e-05 | 46 | 32 | 3 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 4.92e-05 | 46 | 32 | 3 | GO:0072574 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 5.25e-05 | 47 | 32 | 3 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 5.25e-05 | 47 | 32 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 5.25e-05 | 47 | 32 | 3 | GO:0034104 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 5.95e-05 | 49 | 32 | 3 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 5.95e-05 | 49 | 32 | 3 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 6.33e-05 | 50 | 32 | 3 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 7.12e-05 | 52 | 32 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 7.54e-05 | 53 | 32 | 3 | GO:0034110 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 8.89e-05 | 56 | 32 | 3 | GO:0002418 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 9.47e-05 | 1269 | 32 | 9 | GO:0009887 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.04e-04 | 59 | 32 | 3 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 1.09e-04 | 60 | 32 | 3 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 1.09e-04 | 60 | 32 | 3 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 1.15e-04 | 61 | 32 | 3 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.45e-04 | 66 | 32 | 3 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 1.52e-04 | 67 | 32 | 3 | GO:0045601 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.66e-04 | 69 | 32 | 3 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.73e-04 | 70 | 32 | 3 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 1.73e-04 | 70 | 32 | 3 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 1.80e-04 | 71 | 32 | 3 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.80e-04 | 71 | 32 | 3 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 1.88e-04 | 72 | 32 | 3 | GO:0032692 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.88e-04 | 72 | 32 | 3 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 1.96e-04 | 73 | 32 | 3 | GO:0042304 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 1.99e-04 | 1399 | 32 | 9 | GO:0045892 | |
| GeneOntologyBiologicalProcess | regulation of ketone metabolic process | 2.01e-04 | 189 | 32 | 4 | GO:0010565 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 2.21e-04 | 76 | 32 | 3 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 2.57e-04 | 80 | 32 | 3 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 2.57e-04 | 80 | 32 | 3 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | 2.60e-04 | 375 | 32 | 5 | GO:0001933 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.86e-04 | 83 | 32 | 3 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 3.07e-04 | 85 | 32 | 3 | GO:1903670 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 3.07e-04 | 85 | 32 | 3 | GO:0002762 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 3.18e-04 | 86 | 32 | 3 | GO:0042058 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 3.29e-04 | 87 | 32 | 3 | GO:0001974 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorylation | 3.54e-04 | 401 | 32 | 5 | GO:0042326 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 3.76e-04 | 91 | 32 | 3 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 3.76e-04 | 91 | 32 | 3 | GO:0030193 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 3.96e-04 | 906 | 32 | 7 | GO:0043009 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 4.00e-04 | 93 | 32 | 3 | GO:1900046 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 4.00e-04 | 93 | 32 | 3 | GO:1901184 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 4.26e-04 | 95 | 32 | 3 | GO:0070527 | |
| GeneOntologyBiologicalProcess | hemopoiesis | 4.37e-04 | 1223 | 32 | 8 | GO:0030097 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 4.39e-04 | 96 | 32 | 3 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 4.39e-04 | 96 | 32 | 3 | GO:0050818 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 4.60e-04 | 929 | 32 | 7 | GO:0009792 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 4.67e-04 | 98 | 32 | 3 | GO:0061045 | |
| GeneOntologyBiologicalProcess | bone resorption | 4.81e-04 | 99 | 32 | 3 | GO:0045453 | |
| GeneOntologyBiologicalProcess | regulation of lipid biosynthetic process | 5.46e-04 | 246 | 32 | 4 | GO:0046890 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 5.46e-04 | 246 | 32 | 4 | GO:0045216 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 5.71e-04 | 105 | 32 | 3 | GO:0042267 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 6.03e-04 | 107 | 32 | 3 | GO:0042130 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 6.37e-04 | 109 | 32 | 3 | GO:0002228 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 7.26e-04 | 114 | 32 | 3 | GO:0045824 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 7.63e-04 | 116 | 32 | 3 | GO:0045670 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 7.77e-04 | 727 | 32 | 6 | GO:0032870 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.98e-06 | 16 | 33 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 5.05e-05 | 7 | 33 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 6.73e-05 | 8 | 33 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | chromatin | 3.55e-04 | 1480 | 33 | 9 | GO:0000785 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 3.83e-04 | 90 | 33 | 3 | GO:0016328 | |
| GeneOntologyCellularComponent | ciliary membrane | 4.92e-04 | 98 | 33 | 3 | GO:0060170 | |
| GeneOntologyCellularComponent | cell projection membrane | 5.37e-04 | 431 | 33 | 5 | GO:0031253 | |
| GeneOntologyCellularComponent | transferase complex | 6.43e-04 | 963 | 33 | 7 | GO:1990234 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.84e-03 | 335 | 33 | 4 | GO:0061695 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.92e-03 | 157 | 33 | 3 | GO:1902554 | |
| GeneOntologyCellularComponent | T cell receptor complex | 2.14e-03 | 163 | 33 | 3 | GO:0042101 | |
| GeneOntologyCellularComponent | protein kinase complex | 2.41e-03 | 170 | 33 | 3 | GO:1902911 | |
| GeneOntologyCellularComponent | adherens junction | 4.48e-03 | 212 | 33 | 3 | GO:0005912 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 9.65e-03 | 94 | 33 | 2 | GO:0000123 | |
| MousePheno | decreased carbon dioxide production | 4.52e-07 | 31 | 29 | 4 | MP:0008964 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 5.35e-06 | 17 | 29 | 3 | MP:0031047 | |
| MousePheno | abnormal circulating leptin level | 7.45e-06 | 236 | 29 | 6 | MP:0005667 | |
| MousePheno | increased skeletal muscle triglyceride level | 1.04e-05 | 21 | 29 | 3 | MP:0031415 | |
| MousePheno | abnormal carbon dioxide production | 1.05e-05 | 67 | 29 | 4 | MP:0008962 | |
| MousePheno | decreased fatty acid oxidation | 1.58e-05 | 24 | 29 | 3 | MP:0014172 | |
| MousePheno | decreased oxygen consumption | 2.02e-05 | 79 | 29 | 4 | MP:0005290 | |
| MousePheno | increased abdominal fat pad weight | 2.27e-05 | 27 | 29 | 3 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 2.54e-05 | 28 | 29 | 3 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 3.47e-05 | 31 | 29 | 3 | MP:0031413 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 5.02e-05 | 35 | 29 | 3 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 5.47e-05 | 36 | 29 | 3 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 6.98e-05 | 39 | 29 | 3 | MP:0030022 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 1.00e-04 | 44 | 29 | 3 | MP:0031023 | |
| MousePheno | decreased energy expenditure | 1.01e-04 | 119 | 29 | 4 | MP:0004890 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.22e-04 | 47 | 29 | 3 | MP:0031617 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 1.39e-04 | 49 | 29 | 3 | MP:0020948 | |
| MousePheno | decreased cellular glucose uptake | 1.75e-04 | 53 | 29 | 3 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 1.85e-04 | 54 | 29 | 3 | MP:0010953 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 2.54e-04 | 60 | 29 | 3 | MP:0009790 | |
| MousePheno | abnormal colon morphology | 2.58e-04 | 152 | 29 | 4 | MP:0000495 | |
| MousePheno | abnormal lipid oxidation | 2.66e-04 | 61 | 29 | 3 | MP:0010951 | |
| MousePheno | increased insulin secretion | 3.07e-04 | 64 | 29 | 3 | MP:0003058 | |
| MousePheno | abnormal muscle cell glucose uptake | 3.52e-04 | 67 | 29 | 3 | MP:0004130 | |
| MousePheno | abnormal energy expenditure | 4.16e-04 | 313 | 29 | 5 | MP:0005450 | |
| MousePheno | abnormal vascular wound healing | 4.53e-04 | 73 | 29 | 3 | MP:0004883 | |
| MousePheno | abnormal energy homeostasis | 4.74e-04 | 322 | 29 | 5 | MP:0005448 | |
| MousePheno | polyphagia | 5.92e-04 | 80 | 29 | 3 | MP:0001433 | |
| MousePheno | decreased susceptibility to Riboviria infection | 6.37e-04 | 82 | 29 | 3 | MP:0020914 | |
| MousePheno | abnormal oxygen consumption | 6.64e-04 | 195 | 29 | 4 | MP:0005288 | |
| MousePheno | insulin resistance | 6.89e-04 | 197 | 29 | 4 | MP:0005331 | |
| MousePheno | abnormal cellular glucose uptake | 1.20e-03 | 102 | 29 | 3 | MP:0003925 | |
| MousePheno | decreased respiratory quotient | 1.49e-03 | 110 | 29 | 3 | MP:0010379 | |
| Domain | IRO | 4.25e-05 | 6 | 32 | 2 | SM00548 | |
| Domain | Iroquois_homeo | 4.25e-05 | 6 | 32 | 2 | IPR003893 | |
| Domain | Enhancer_polycomb-like_N | 7.91e-05 | 8 | 32 | 2 | IPR019542 | |
| Domain | EPL1 | 7.91e-05 | 8 | 32 | 2 | PF10513 | |
| Domain | - | 1.11e-04 | 283 | 32 | 5 | 1.10.10.60 | |
| Domain | Znf_FYVE_PHD | 1.12e-04 | 147 | 32 | 4 | IPR011011 | |
| Domain | Zinc_finger_PHD-type_CS | 1.86e-04 | 65 | 32 | 3 | IPR019786 | |
| Domain | Homeodomain-like | 2.34e-04 | 332 | 32 | 5 | IPR009057 | |
| Domain | Ig_2 | 2.62e-04 | 73 | 32 | 3 | PF13895 | |
| Domain | V-set | 2.64e-04 | 184 | 32 | 4 | PF07686 | |
| Domain | Homeobox_CS | 2.75e-04 | 186 | 32 | 4 | IPR017970 | |
| Domain | PHD | 2.84e-04 | 75 | 32 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 3.31e-04 | 79 | 32 | 3 | IPR019787 | |
| Domain | Ig_V-set | 3.56e-04 | 199 | 32 | 4 | IPR013106 | |
| Domain | Homeobox_KN | 3.81e-04 | 17 | 32 | 2 | PF05920 | |
| Domain | Homeobox_KN_domain | 3.81e-04 | 17 | 32 | 2 | IPR008422 | |
| Domain | PHD | 4.69e-04 | 89 | 32 | 3 | SM00249 | |
| Domain | Znf_PHD | 5.01e-04 | 91 | 32 | 3 | IPR001965 | |
| Domain | PWWP | 5.30e-04 | 20 | 32 | 2 | SM00293 | |
| Domain | ZF_PHD_2 | 5.68e-04 | 95 | 32 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 5.86e-04 | 96 | 32 | 3 | PS01359 | |
| Domain | EPHD | 6.43e-04 | 22 | 32 | 2 | PS51805 | |
| Domain | Homeobox | 6.56e-04 | 234 | 32 | 4 | PF00046 | |
| Domain | IGc2 | 6.66e-04 | 235 | 32 | 4 | SM00408 | |
| Domain | Ig_sub2 | 6.66e-04 | 235 | 32 | 4 | IPR003598 | |
| Domain | HOMEOBOX_1 | 6.77e-04 | 236 | 32 | 4 | PS00027 | |
| Domain | HOX | 6.88e-04 | 237 | 32 | 4 | SM00389 | |
| Domain | PWWP | 7.04e-04 | 23 | 32 | 2 | PF00855 | |
| Domain | PWWP_dom | 7.04e-04 | 23 | 32 | 2 | IPR000313 | |
| Domain | Homeobox_dom | 7.10e-04 | 239 | 32 | 4 | IPR001356 | |
| Domain | HOMEOBOX_2 | 7.10e-04 | 239 | 32 | 4 | PS50071 | |
| Domain | PWWP | 7.67e-04 | 24 | 32 | 2 | PS50812 | |
| Domain | Bromodomain_CS | 9.01e-04 | 26 | 32 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 1.82e-03 | 37 | 32 | 2 | PS00633 | |
| Domain | SOCS_box | 1.92e-03 | 38 | 32 | 2 | PF07525 | |
| Domain | Bromodomain | 1.92e-03 | 38 | 32 | 2 | PF00439 | |
| Domain | SOCS | 2.03e-03 | 39 | 32 | 2 | PS50225 | |
| Domain | SOCS_box | 2.03e-03 | 39 | 32 | 2 | SM00969 | |
| Domain | SOCS_box | 2.03e-03 | 39 | 32 | 2 | IPR001496 | |
| Domain | BROMODOMAIN_2 | 2.24e-03 | 41 | 32 | 2 | PS50014 | |
| Domain | BROMO | 2.35e-03 | 42 | 32 | 2 | SM00297 | |
| Domain | Bromodomain | 2.35e-03 | 42 | 32 | 2 | IPR001487 | |
| Domain | - | 2.35e-03 | 42 | 32 | 2 | 1.20.920.10 | |
| Domain | ig | 4.14e-03 | 190 | 32 | 3 | PF00047 | |
| Domain | Immunoglobulin | 4.14e-03 | 190 | 32 | 3 | IPR013151 | |
| Domain | IG | 5.55e-03 | 421 | 32 | 4 | SM00409 | |
| Domain | Ig_sub | 5.55e-03 | 421 | 32 | 4 | IPR003599 | |
| Domain | Ank_2 | 5.83e-03 | 215 | 32 | 3 | PF12796 | |
| Domain | HTH_motif | 6.21e-03 | 69 | 32 | 2 | IPR000047 | |
| Domain | Ank | 6.86e-03 | 228 | 32 | 3 | PF00023 | |
| Domain | - | 6.96e-03 | 449 | 32 | 4 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 7.51e-03 | 459 | 32 | 4 | IPR013083 | |
| Domain | - | 8.64e-03 | 248 | 32 | 3 | 1.25.40.20 | |
| Domain | ANK | 8.92e-03 | 251 | 32 | 3 | SM00248 | |
| Domain | ANK_REPEAT | 9.12e-03 | 253 | 32 | 3 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 9.22e-03 | 254 | 32 | 3 | IPR020683 | |
| Domain | ANK_REP_REGION | 9.22e-03 | 254 | 32 | 3 | PS50297 | |
| Domain | IG_LIKE | 9.47e-03 | 491 | 32 | 4 | PS50835 | |
| Domain | Ankyrin_rpt | 1.00e-02 | 262 | 32 | 3 | IPR002110 | |
| Domain | Ig-like_dom | 1.03e-02 | 503 | 32 | 4 | IPR007110 | |
| Domain | Homeobox_metazoa | 1.04e-02 | 90 | 32 | 2 | IPR020479 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.86e-04 | 188 | 22 | 4 | MM15828 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 4.70e-04 | 99 | 22 | 3 | MM14624 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 9.20e-04 | 29 | 22 | 2 | MM15340 | |
| Pathway | WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME | 9.20e-04 | 29 | 22 | 2 | M39890 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 9.85e-04 | 30 | 22 | 2 | M27637 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ANKRD11 C15orf39 DACT1 NCOR2 TNRC18 TULP4 SBF2 ZBTB4 SOCS3 SEC16A | 4.79e-08 | 1105 | 33 | 10 | 35748872 |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 26219866 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 2.21e-07 | 13 | 33 | 3 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 2.21e-07 | 13 | 33 | 3 | 1985902 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 15207636 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 7628460 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 19285068 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 25724769 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 18003729 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 21760897 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 26284027 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 2133556 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 32521208 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 26374765 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 1719235 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 2.21e-07 | 13 | 33 | 3 | 33352461 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 19406938 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 10964771 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 38381498 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 32169849 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 20739537 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 2.21e-07 | 13 | 33 | 3 | 19273835 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 19621080 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 2.21e-07 | 13 | 33 | 3 | 25972571 | |
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 2.21e-07 | 13 | 33 | 3 | 29967450 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 2.21e-07 | 13 | 33 | 3 | 16638824 | |
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 2.21e-07 | 13 | 33 | 3 | 1326665 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 20044046 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 1633107 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 32150576 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 21081647 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 2.21e-07 | 13 | 33 | 3 | 39168268 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 22469976 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 11483763 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 2.21e-07 | 13 | 33 | 3 | 19358828 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 2.21e-07 | 13 | 33 | 3 | 21532628 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 2.21e-07 | 13 | 33 | 3 | 27695943 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 2.21e-07 | 13 | 33 | 3 | 28035001 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 2.21e-07 | 13 | 33 | 3 | 12832451 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 2.21e-07 | 13 | 33 | 3 | 15316023 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 8402684 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 20404914 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 2.21e-07 | 13 | 33 | 3 | 22092845 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 16680193 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 2.21e-07 | 13 | 33 | 3 | 21670291 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 22162753 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 11801635 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 2164599 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 26911181 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 1653760 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 2.21e-07 | 13 | 33 | 3 | 23935487 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 2702644 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 28913658 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 16619040 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 2.21e-07 | 13 | 33 | 3 | 32027621 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 19008452 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 8380065 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 18544705 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 1279194 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 2.21e-07 | 13 | 33 | 3 | 27777319 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 15331748 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 29377208 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 2.21e-07 | 13 | 33 | 3 | 15220458 | |
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 2.21e-07 | 13 | 33 | 3 | 8209741 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 2.21e-07 | 13 | 33 | 3 | 22406619 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 18848945 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 2.21e-07 | 13 | 33 | 3 | 8500759 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 2.21e-07 | 13 | 33 | 3 | 21949477 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 2.21e-07 | 13 | 33 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 2.21e-07 | 13 | 33 | 3 | 23800882 | |
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 29396368 | ||
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 37531413 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 2.81e-07 | 14 | 33 | 3 | 18794798 | |
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 23780386 | ||
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 28567513 | ||
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 31083261 | ||
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 8207827 | ||
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 23469261 | ||
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 18454175 | ||
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 1648219 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 2.81e-07 | 14 | 33 | 3 | 26196244 | |
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 10491101 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 2.81e-07 | 14 | 33 | 3 | 17081782 | |
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 2.81e-07 | 14 | 33 | 3 | 34666041 | |
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 8896983 | ||
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 19700760 | ||
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 22159884 | ||
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 34619794 | ||
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 29907459 | ||
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 2.81e-07 | 14 | 33 | 3 | 32209360 | |
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 22962327 | ||
| Pubmed | 2.81e-07 | 14 | 33 | 3 | 17623671 | ||
| Interaction | SOX7 interactions | 2.14e-07 | 82 | 33 | 5 | int:SOX7 | |
| Interaction | EGR2 interactions | 3.13e-07 | 171 | 33 | 6 | int:EGR2 | |
| Interaction | CTBP1 interactions | 3.48e-06 | 406 | 33 | 7 | int:CTBP1 | |
| Interaction | GUSBP5 interactions | 6.67e-06 | 75 | 33 | 4 | int:GUSBP5 | |
| Interaction | RCOR1 interactions | 1.25e-05 | 494 | 33 | 7 | int:RCOR1 | |
| Interaction | FOLR3 interactions | 5.43e-05 | 7 | 33 | 2 | int:FOLR3 | |
| Interaction | CRX interactions | 5.44e-05 | 254 | 33 | 5 | int:CRX | |
| Interaction | CELSR3 interactions | 5.79e-05 | 46 | 33 | 3 | int:CELSR3 | |
| Interaction | PSG4 interactions | 7.24e-05 | 8 | 33 | 2 | int:PSG4 | |
| Interaction | PSG1 interactions | 7.90e-05 | 51 | 33 | 3 | int:PSG1 | |
| Interaction | TOP3B interactions | ANKRD11 C15orf39 DACT1 NCOR2 TNRC18 TULP4 SBF2 ZBTB4 SOCS3 SEC16A | 8.08e-05 | 1470 | 33 | 10 | int:TOP3B |
| Interaction | HDAC3 interactions | 1.45e-04 | 313 | 33 | 5 | int:HDAC3 | |
| Interaction | DTX2 interactions | 1.86e-04 | 330 | 33 | 5 | int:DTX2 | |
| Interaction | ALG13 interactions | 2.19e-04 | 183 | 33 | 4 | int:ALG13 | |
| Interaction | ING4 interactions | 2.80e-04 | 78 | 33 | 3 | int:ING4 | |
| Interaction | HDAC1 interactions | 3.29e-04 | 1108 | 33 | 8 | int:HDAC1 | |
| Interaction | TLE3 interactions | 3.40e-04 | 376 | 33 | 5 | int:TLE3 | |
| Interaction | GSC interactions | 3.86e-04 | 87 | 33 | 3 | int:GSC | |
| Interaction | ERG interactions | 4.64e-04 | 223 | 33 | 4 | int:ERG | |
| Interaction | TBX19 interactions | 4.85e-04 | 20 | 33 | 2 | int:TBX19 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.84e-04 | 1192 | 33 | 6 | chr19q13 | |
| Cytoband | 19q13.2 | 2.26e-04 | 164 | 33 | 3 | 19q13.2 | |
| Cytoband | 17q25.3 | 2.42e-03 | 101 | 33 | 2 | 17q25.3 | |
| Cytoband | 19q13.42 | 3.67e-03 | 125 | 33 | 2 | 19q13.42 | |
| Cytoband | 11p15.4 | 9.12e-03 | 200 | 33 | 2 | 11p15.4 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 3.83e-07 | 11 | 25 | 3 | 1315 | |
| GeneFamily | PHD finger proteins | 2.53e-04 | 90 | 25 | 3 | 88 | |
| GeneFamily | PWWP domain containing | 4.17e-04 | 22 | 25 | 2 | 1147 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.40e-04 | 25 | 25 | 2 | 775 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 5.85e-04 | 26 | 25 | 2 | 526 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.43e-03 | 163 | 25 | 3 | 590 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 3.84e-03 | 67 | 25 | 2 | 519 | |
| GeneFamily | Ankyrin repeat domain containing | 4.38e-03 | 242 | 25 | 3 | 403 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 7.11e-07 | 135 | 33 | 5 | MM965 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | 9.87e-07 | 436 | 33 | 7 | MM1326 | |
| Coexpression | TGFB_UP.V1_UP | 3.72e-06 | 189 | 33 | 5 | M2839 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 7.63e-06 | 219 | 33 | 5 | MM3826 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 8.80e-06 | 32 | 33 | 3 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.16e-05 | 35 | 33 | 3 | MM757 | |
| Coexpression | MARTIN_INTERACT_WITH_HDAC | 1.88e-05 | 41 | 33 | 3 | M15154 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 2.17e-05 | 272 | 33 | 5 | M1938 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 2.58e-05 | 282 | 33 | 5 | MM822 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 3.03e-05 | 48 | 33 | 3 | MM531 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 4.65e-05 | 159 | 33 | 4 | MM760 | |
| Coexpression | GSE16266_CTRL_VS_LPS_STIM_MEF_UP | 1.09e-04 | 198 | 33 | 4 | M7219 | |
| Coexpression | GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_UP | 1.11e-04 | 199 | 33 | 4 | M7067 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 1.15e-04 | 75 | 33 | 3 | MM605 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 1.26e-04 | 394 | 33 | 5 | MM3724 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 1.75e-04 | 224 | 33 | 4 | M40145 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 1.79e-04 | 87 | 33 | 3 | MM851 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 1.94e-04 | 230 | 33 | 4 | MM986 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 2.18e-04 | 93 | 33 | 3 | M40279 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 2.32e-04 | 18 | 33 | 2 | M1388 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 4.20e-04 | 795 | 33 | 6 | M39050 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 4.31e-04 | 284 | 33 | 4 | MM987 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#4_top-relative-expression-ranked_500 | 4.12e-06 | 70 | 33 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.08e-05 | 132 | 33 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k4 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 196 | 33 | 4 | 6e08d7ba67da161c2dca1a17c440ffb9d9b5bc3b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 196 | 33 | 4 | 547901c7a665770eff78eede69b8625b416c8186 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Nefm|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.32e-05 | 62 | 33 | 3 | 3eec7f31de7cc24762c5b180475650676437dc76 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Nefm-Inhibitory_Neuron.Chat-Gad1Gad2-Slc17a8.Nefm_(Globus_Pallidus/Nucleus_Basalis_(GP/NB),_cholinergic)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.32e-05 | 62 | 33 | 3 | f5f5441f5be00ab80a7827c4af1afbe45c552c2e | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Nefm-Inhibitory_Neuron.Chat-Gad1Gad2-Slc17a8.Nefm_(Globus_Pallidus/Nucleus_Basalis_(GP/NB),_cholinergic)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.32e-05 | 62 | 33 | 3 | 6e81a37b9defa96528654bee1b23152108d9c0b7 | |
| Computational | Neighborhood of CDKN1C | 7.13e-04 | 27 | 16 | 2 | GNF2_CDKN1C | |
| Computational | Neighborhood of TNFRSF25 | 8.82e-04 | 30 | 16 | 2 | CAR_TNFRSF25 | |
| Computational | Neighborhood of EGFR | 1.00e-03 | 32 | 16 | 2 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 1.20e-03 | 35 | 16 | 2 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 1.73e-03 | 42 | 16 | 2 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 2.07e-03 | 46 | 16 | 2 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 2.35e-03 | 49 | 16 | 2 | GNF2_KISS1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.35e-03 | 49 | 16 | 2 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | Pimozide [2062-78-4]; Up 200; 8.6uM; HL60; HG-U133A | 7.93e-06 | 192 | 33 | 5 | 1562_UP | |
| Disease | cD177 antigen measurement | 9.35e-07 | 18 | 32 | 3 | EFO_0021866 | |
| Disease | Clear cell sarcoma of kidney | 1.70e-05 | 6 | 32 | 2 | C0334488 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.26e-04 | 239 | 32 | 4 | EFO_0008317, EFO_0020945 | |
| Disease | iritis | 1.53e-04 | 17 | 32 | 2 | EFO_1000997 | |
| Disease | hypospadias | 8.23e-04 | 39 | 32 | 2 | EFO_0004209 | |
| Disease | eosinophil count | 9.05e-04 | 1488 | 32 | 7 | EFO_0004842 | |
| Disease | sexual dimorphism measurement | 1.07e-03 | 1106 | 32 | 6 | EFO_0021796 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.82e-03 | 224 | 32 | 3 | EFO_0004574, EFO_0008317 | |
| Disease | Atherogenesis | 1.88e-03 | 59 | 32 | 2 | C1563937 | |
| Disease | Atherosclerosis | 1.88e-03 | 59 | 32 | 2 | C0004153 | |
| Disease | squamous cell carcinoma | 2.41e-03 | 67 | 32 | 2 | EFO_0000707 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.29e-03 | 276 | 32 | 3 | EFO_0004612, EFO_0020943 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.27e-03 | 303 | 32 | 3 | EFO_0004612, EFO_0020945 | |
| Disease | mean fractional anisotropy measurement | 4.78e-03 | 95 | 32 | 2 | EFO_0008399 | |
| Disease | body surface area | 4.95e-03 | 643 | 32 | 4 | EFO_0022196 | |
| Disease | Adenoid Cystic Carcinoma | 5.28e-03 | 100 | 32 | 2 | C0010606 | |
| Disease | Hypermetropia | 5.59e-03 | 103 | 32 | 2 | HP_0000540 | |
| Disease | remnant cholesterol measurement | 6.13e-03 | 108 | 32 | 2 | EFO_0010815 | |
| Disease | lipoprotein A measurement | 6.58e-03 | 112 | 32 | 2 | EFO_0006925 | |
| Disease | viral load | 9.55e-03 | 136 | 32 | 2 | EFO_0010125 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EYSPPSAPRRPPVYY | 126 | O95696 | |
| LSPGYYSPDYGLPSP | 1846 | Q6UB99 | |
| ALYLYRGPSAPPPAL | 276 | Q9BZE3 | |
| IQPEAPPLPAAYYRY | 126 | Q9ULD4 | |
| PPLPAAYYRYIEKPP | 131 | Q9ULD4 | |
| FRSPPIPYPRSYLPY | 646 | Q6W2J9 | |
| IPYPRSYLPYPAPEG | 651 | Q6W2J9 | |
| IRPLTKIPPYHGPYY | 261 | Q6P1M9 | |
| PSVLPYTSRPYSYPG | 491 | Q8TBY0 | |
| YTSRPYSYPGYPLSP | 496 | Q8TBY0 | |
| GYLPYSPEPPSLYGA | 86 | P78412 | |
| YPHLYPPYLIRGYPD | 1661 | Q9Y618 | |
| FPLKYSYPYIPILPA | 246 | Q86WG5 | |
| PYPASPLLGRPLYYT | 371 | Q9BZI1 | |
| PYGIRNLPPPLYYRP | 41 | Q6MZM9 | |
| PPSLLPLQPSYYYPY | 301 | P78367 | |
| PAPVPLPYASPYAYV | 706 | Q9NYF0 | |
| YPTYRLGYPQAPPSG | 701 | Q96J84 | |
| YVPYNILTPYPGPRL | 526 | Q8TE68 | |
| ALYYPGALLPLYPTR | 81 | P20749 | |
| GPDLPRIYPSFTYYR | 331 | P11464 | |
| YKPLPSSNPYLGPGY | 81 | Q9Y3Y4 | |
| LTYPDYRPPPKLYRY | 206 | Q9HCM1 | |
| YRPPPKLYRYSPQSF | 211 | Q9HCM1 | |
| GPDLPRIYPSFTYYR | 331 | Q9UQ74 | |
| GPDLPRIYPSFTYYR | 331 | Q00887 | |
| YSSPRIYLPRPPCSY | 261 | O75603 | |
| QAPYIPPLGLDAYPY | 331 | Q6ZRI6 | |
| RYPFQALPPHYGRPY | 1081 | O15417 | |
| YPSNLPIPYGFYRPE | 311 | Q32MQ0 | |
| YPPSLSYCTLPPMYP | 1231 | Q9NRJ4 | |
| RYPFPGRLLPYFSPC | 451 | Q6AZZ1 | |
| PPPQDLAAYYYYRPL | 1151 | O15027 | |
| WSPLFYGFYPPRPRL | 236 | Q7Z404 | |
| YGFYPPRPRLAVTYL | 241 | Q7Z404 | |
| PYVRPLPPSYLDERY | 1046 | Q8IZM8 | |
| PYPLVYGPQLLAAYP | 921 | Q9P1Z0 | |
| LPGSPPRRAYYIYSG | 156 | O14543 |